Effectiveness and Safety of YVOIRE Y-Solution 540

NACompletedINTERVENTIONAL
Enrollment

394

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

September 29, 2022

Study Completion Date

July 14, 2024

Conditions
Wrinkles in the Nasolabial Folds
Interventions
DEVICE

YVOIRE Y-Solution 540

Injection into the deep dermis layer and/or subcutaneous layer in the nasolabial folds based on the randomization assignment.

DEVICE

YVOIRE volume plus

Injection into the deep dermis layer and/or subcutaneous layer in the nasolabial folds based on the randomization assignment.

Trial Locations (1)

Unknown

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT04855188 - Effectiveness and Safety of YVOIRE Y-Solution 540 | Biotech Hunter | Biotech Hunter